Carcinoma in situ of skin of right lower limb, including hip
ICD-10 D04.71 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of right lower limb, including hip.
Carcinoma in situ (CIS) of the skin is a non-invasive form of skin cancer characterized by the presence of abnormal cells confined to the epidermis. In the case of D04.71, the carcinoma is specifically located on the right lower limb, including the hip area. This condition is often associated with prolonged sun exposure, fair skin, and a history of skin lesions. Patients may present with various skin changes, including scaly patches, non-healing sores, or changes in existing moles. Diagnosis typically involves a biopsy to confirm the presence of atypical keratinocytes. While CIS is not life-threatening, it has the potential to progress to invasive squamous cell carcinoma if left untreated. Therefore, early detection and management are crucial. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy. Regular follow-up and skin surveillance are essential to monitor for any signs of progression or new lesions.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Diagnosis and treatment of skin lesions, follow-up for skin cancer surveillance.
Ensure accurate documentation of the lesion's characteristics and location.
Comprehensive treatment plans, including surgical and non-surgical interventions.
Management of skin cancers, including CIS and its progression.
Document any multidisciplinary approaches to treatment.
Used when a biopsy is performed to confirm CIS.
Document the site, size, and method of biopsy.
Dermatologists should ensure detailed lesion descriptions.
Carcinoma in situ is a non-invasive cancer where abnormal cells are present but have not spread beyond the original tissue layer.
Treatment options include surgical excision, cryotherapy, and topical chemotherapy, depending on the lesion's characteristics.
